Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelon: a randomized controlled study

Phase 1

• Conditions: Peripheral nerve diseases; Cancer

• Registration Number: ITMCTR2200006507
• Lead Sponsor: Zhejiang Cancer Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

? According to the diagnostic criteria of CIPN, recent use of utidelon chemotherapy resulted in grade I and above peripheral neuropathy; ? Age 18-70 years old; ? Have the ability of daily living, Karnofsky function score > 70, and can cooperate independently to complete all treatments; ? No severe diseases such as gravity center, liver, brain and kidney, and no serious mental diseases; ? Voluntarily participate and sign informed consent.

Exclusion Criteria

? Those who do not meet the above requirements; ? Pregnant women, or combined with other serious diseases, end-stage cachexia, etc; ? Peripheral neuropathy caused by other diseases; ? Those who do not cooperate with the treatment or are participating in other acupuncture or drug clinical trials; ? Those who do not agree to participate in the clinical trial or cannot follow up on time.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peripheral neurotoxicity was assessed according to NCI CTCAE version 5.0;PNQ;EORTC QLQ-CIPN20;

Secondary Outcome Measures

Name	Time	Method
EORTC QLQ-C30;